Therapeutic Nuclear Medicines Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Therapeutic Nuclear Medicines Market contains market size and forecasts of Therapeutic Nuclear Medicines in global, including the following market information:

Global Therapeutic Nuclear Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Therapeutic Nuclear Medicines Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Therapeutic Nuclear Medicines companies in 2021 (%)

The global Therapeutic Nuclear Medicines market was valued at 1719.4 million in 2021 and is projected to reach US$ 5230.4 million by 2028, at a CAGR of 17.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Radium-223 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus and Acrotech Biopharma., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Nuclear Medicines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Therapeutic Nuclear Medicines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Therapeutic Nuclear Medicines Market Segment Percentages, by Type, 2021 (%)

Radium-223

Lutetium-177

Iodine-131

Other

Global Therapeutic Nuclear Medicines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Therapeutic Nuclear Medicines Market Segment Percentages, by Application, 2021 (%)

Thyroid

Bone Metastasis

Lymphoma

Other

Global Therapeutic Nuclear Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Therapeutic Nuclear Medicines Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Therapeutic Nuclear Medicines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Therapeutic Nuclear Medicines revenues share in global market, 2021 (%)

Key companies Therapeutic Nuclear Medicines sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Therapeutic Nuclear Medicines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novartis AG

Bayer

China Isotope & Radiation

Q BioMed

Curium Pharmaceuticals

Jubilant DraxImage

Dongcheng

Lantheus

Acrotech Biopharma.

Progenics Pharmaceuticals

International Isotopes